시장보고서
상품코드
1624004

스마트 필 기술 시장 규모, 점유율, 성장 분석(대상 영역별, 적용 질환별, 용도별, 최종사용자별, 지역별) : 산업 예측(2025-2032년)

Smart Pills Technology Market Size, Share, Growth Analysis, By Target Area (Esophagus, Stomach), By Disease Indication (Barretts Esophagus, Small Bowel Diseases), By Application, By End User, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 264 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 스마트 필 기술 시장 규모는 2023년 39억 달러로 평가되며, 2024년 42억 3,000만 달러에서 2032년 81억 3,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.5%의 CAGR을 기록할 것으로 예상됩니다.

스마트 필은 디지털 건강 분야의 중요한 발전으로, 캡슐과 같은 디자인과 감지, 영상화, 표적 약물전달과 같은 첨단 기능을 갖춘 것이 특징입니다. 이 혁신적인 장치는 소화관을 통과해 기존에는 어려웠던 진단 이미지를 획득할 수 있으며, 내시경과 같은 전통적인 방법에 대한 비침습적 대안으로 효과적으로 작용할 수 있습니다. 스마트 필은 종종 의료 전문가가 환자의 데이터를 면밀히 모니터링할 수 있도록 의료 서비스 제공자 포털 및 모바일 앱과 통신하는 웨어러블 센서 패치와 통합되어 있습니다. 위 마비, 변비 등 소화기 질환의 진단을 용이하게 하고 복약 순응도를 높일 수 있습니다. 이 시스템은 맥박수, 체온, 위 pH와 같은 중요한 지표를 수집하여 환자의 건강 상태를 포괄적으로 파악하여 위장 질환의 진단 및 관리 접근 방식을 혁신적으로 변화시킬 수 있습니다.

목차

소개

  • 분석 목적
  • 시장 범위
  • 정의

분석 방법

  • 정보 조달
  • 2차·1차 데이터 방법
  • 시장 규모 예측
  • 시장 상정과 제약

주요 요약

  • 시장 개요와 전망
  • 수급 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porters 분석

시장의 주요 인사이트

  • 주요 성공요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장 매력도 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 기술 분석
  • 규제 분석
  • 특허 분석
  • 사례 연구

세계의 스마트 필 기술 시장 규모·CAGR : 대상 영역별(2025-2032년)

  • 시장 개요
  • 식도
  • 소장
  • 대장

세계의 스마트 필 기술 시장 규모·CAGR : 적용 질환별(2025-2032년)

  • 시장 개요
  • 바렛 식도
  • 소장 질환
  • 대장암
  • 기타

세계의 스마트 필 기술 시장 규모·CAGR : 용도별(2025-2032년)

  • 시장 개요
  • 캡슐 내시경
  • 약물전달
  • 환자 모니터링
  • 기타

세계의 스마트 필 기술 시장 규모·CAGR : 최종사용자별(2025-2032년)

  • 시장 개요
  • 병원·진료소
  • 진단 센터
  • 연구 센터

세계의 스마트 필 기술 시장 규모·CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 기업이 채용한 전략
  • 시장의 최근 동향
  • 주요 기업의 시장 점유율(2024년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출 전년비 비교(2022-2024년)

주요 기업 개요

  • IntroMedic Co., Ltd.(한국)
  • CapsoVision, Inc.(미국)
  • Koninklijke Philips N.V.(네덜란드)
  • Olympus Corporation(일본)
  • RF Co., Ltd.(일본)
  • HQ, Inc.(미국)
  • Proteus Digital Health(미국)
  • Medtronic Plc.(아일랜드)
  • Chongqing Jinshan Science & Technology(Group) Co., Ltd.(중국)
  • Check-Cap Ltd.(이스라엘)
  • AnX Robotica Corp.(미국)
  • Shenzhen Jifu Medical Technology Co., Ltd.(중국)
  • etecRx(미국)
  • BodyCap(France)
  • Otsuka America Pharmaceutical, Inc.(미국)
  • GE Healthcare(미국)
  • Boston Scientific Corporation(미국)
  • Given Imaging Ltd.(Now part of Medtronic)(이스라엘)
  • Bio-Images Research Limited(영국)
  • Lucid Diagnostics(미국)

결론과 추천사항

ksm 25.01.21

Global Smart Pills Technology Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.23 billion in 2024 to USD 8.13 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

Smart pills represent a significant advancement in digital health, characterized by their capsule-like design and advanced capabilities such as sensing, imaging, and targeted medication delivery. These innovative devices navigate the gastrointestinal tract to capture diagnostic images that were previously challenging to obtain, effectively serving as non-invasive alternatives to traditional methods like endoscopy. Smart pills often integrate with a wearable sensor patch that communicates with a provider portal and a mobile app, allowing healthcare professionals to closely monitor patient data. They facilitate diagnosis of gastrointestinal conditions, including gastroparesis and constipation, and enhance medication adherence. This system captures vital metrics like pulse rate, body temperature, and gastric pH, offering a comprehensive view of patient health and revolutionizing the approach to diagnosing and managing gastrointestinal disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segmental Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The global smart pills technology market is poised for substantial growth in the foreseeable future, primarily fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Lifestyle factors such as sedentary habits are also contributing to this rising demand, alongside enhanced patient compliance thanks to minimally invasive techniques associated with smart pills. Furthermore, the market is expected to benefit from the evolving health challenges linked to modern lifestyles. As disposable incomes rise in both developed and emerging markets, more individuals will have the financial means to invest in these innovative technologies. The aging population, particularly those susceptible to inflammatory bowel diseases like ulcerative colitis and Crohn's disease, will also serve as a significant driver for market expansion.

Restraints in the Global Smart Pills Technology Market

The Global Smart Pills Technology market faces several constraints that hinder its growth despite the numerous benefits offered by this innovative technology. Key challenges include the limited technological advancement of capsule endoscopes and patients' concerns regarding the ingestion of microchips. Moreover, the high prices associated with ingestible sensors, combined with stringent government regulations governing their usage, further restrict market expansion. In developing countries, inadequate reimbursement policies often result in insufficient patient coverage, exacerbating the issue. Additionally, the technological shortcomings of various smart pill applications impede their widespread adoption throughout the forecast period, posing significant barriers to market progress.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is experiencing significant growth, driven by the increasing demand for innovative, AI-IoT solutions like the Smart Pill Expert System (SPES). As healthcare systems face challenges such as Medical Non-Adherence (MNA), SPES provides a reliable platform for automating medication administration and enhancing patient monitoring in nursing homes, hospices, and home healthcare facilities. Its ability to serve multiple users simultaneously while maintaining a low failure rate underscores its potential to improve medication adherence and patient outcomes. Additionally, the integration of advanced chatbots for real-time health assessments further distinguishes SPES, positioning it as a frontrunner in the evolving healthcare landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis
  • Patent Analysis
  • Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2025-2032)

  • Market Overview
  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2025-2032)

  • Market Overview
  • Barrett'S Esophagus
  • Small Bowel Diseases
  • Colon Cancer
  • Others

Global Smart Pills Technology Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring
  • Others

Global Smart Pills Technology Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Centres
  • Research Centres

Global Smart Pills Technology Market Size & CAGR (2025-2032)

  • North America (Target Area, Disease Indication, Application, End User)
    • US
    • Canada
  • Europe (Target Area, Disease Indication, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Target Area, Disease Indication, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Target Area, Disease Indication, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Target Area, Disease Indication, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IntroMedic Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CapsoVision, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RF Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HQ, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic Plc. (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Check-Cap Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AnX Robotica Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Jifu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • etecRx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BodyCap (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka America Pharmaceutical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Given Imaging Ltd. (Now part of Medtronic) (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Images Research Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lucid Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제